Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.

Many people don’t know they’re eligible. | Moderna has identified a fundamental barrier to vaccination: many people don’t ...

Immunocompromised people and those who are over 65 years of age or older should get a second dose of this year’s COVID-19 ...

There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...

All vaccination locations offering the PfizerBioNTech/Comirnaty and Moderna/Spikevax vaccines will begin administering the ...

The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...